Testing effectiveness (Phase 2)Study completedNCT01119508What this trial is testingIpilimumab + Temozolomide in Metastatic MelanomaWho this might be right forMetastatic Melanoma M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT01961115What this trial is testingEpacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaWho this might be right forMucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04462406What this trial is testingUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop TrialWho this might be right forAdvanced MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+8 more ECOG-ACRIN Cancer Research Group 150
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)UnknownNCT03602547What this trial is testingStudy of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.Who this might be right forMucosal Melanoma AnewPharma 40
Testing effectiveness (Phase 2)WithdrawnNCT03758729What this trial is testingPhase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.Who this might be right forMelanoma Samsung Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)WithdrawnNCT02535078What this trial is testingPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous MelanomaWho this might be right forMalignant Melanoma Immunocore Ltd
Early research (Phase 1)Looking for participantsNCT07600476What this trial is testingA First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid TumorsWho this might be right forCutaneous MelanomaMucosal MelanomaCutaneous Squamous Cell Carcinoma (CSCC)+2 more Kupando GmbH 21
Testing effectiveness (Phase 2)Ended earlyNCT02978443What this trial is testingA Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With IpilimumabWho this might be right forAcral Lentiginous MelanomaMucosal Melanoma Georgetown University 14
Testing effectiveness (Phase 2)Looking for participantsNCT07155317What this trial is testingTime-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialWho this might be right forAdvanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more Emory University 99
Early research (Phase 1)Ended earlyNCT02346955What this trial is testingStudy of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)Who this might be right forNon-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more Famewave Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT01395121What this trial is testingA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has SpreadWho this might be right forMucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma Institute of Cancer Research, United Kingdom 29
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Very early researchUnknownNCT05009446What this trial is testingSingle Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMMWho this might be right forMucosal MelanomaSinonasal Melanoma Eye & ENT Hospital of Fudan University 28
Large-scale testing (Phase 3)Study completedNCT01989572What this trial is testingSargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more National Cancer Institute (NCI) 815
Testing effectiveness (Phase 2)Looking for participantsNCT06999980What this trial is testingNeo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)Who this might be right forCutaneous MelanomaMucosal Melanoma Melanoma Institute Australia 494
Testing effectiveness (Phase 2)UnknownNCT03986515What this trial is testingApatinib Plus SHR1210 in Advanced Mucosal MelanomaWho this might be right forMucosal MelanomaAdvanced CancerApatinib+1 more Henan Cancer Hospital 40
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT05549297What this trial is testingTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Who this might be right forAdvanced Melanoma Immunocore Ltd 540